JENNIFER LORE-AYALA: Open Payments
NPI 1235806332 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,967 in 120 payments from 17 companies in 2025. Trend: 2023 $1,917 · 2024 $2,589 · 2025 $2,967
Food & beverage: $2,867Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $540 |
| Galderma Laboratories, L.P. | 23 | $471 |
| Incyte Corporation | 13 | $302 |
| Janssen Biotech, Inc. | 10 | $272 |
| Botanix SB Inc | 14 | $260 |
| Regeneron Healthcare Solutions, Inc. | 8 | $259 |
| Arcutis Biotherapeutics, Inc. | 8 | $255 |
| Lilly USA, LLC | 8 | $136 |
| PFIZER INC. | 5 | $109 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
Products named: SKYRIZI, OPZELURA, DUPIXENT, TREMFYA, SOFDRA, Zoryve, NEMLUVIO, TALTZ.
Industry payments across NY — which companies pay providers there.
